GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Avacta Group PLC (FRA:RTQ1) » Definitions » Net Margin %

Avacta Group (FRA:RTQ1) Net Margin % : -110.75% (As of Jun. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Avacta Group Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Avacta Group's Net Income for the six months ended in Jun. 2024 was €-14.74 Mil. Avacta Group's Revenue for the six months ended in Jun. 2024 was €13.31 Mil. Therefore, Avacta Group's net margin for the quarter that ended in Jun. 2024 was -110.75%.

The historical rank and industry rank for Avacta Group's Net Margin % or its related term are showing as below:

FRA:RTQ1' s Net Margin % Range Over the Past 10 Years
Min: -894.8   Med: -276.17   Max: -56.33
Current: -114.45


FRA:RTQ1's Net Margin % is ranked better than
52.32% of 1013 companies
in the Biotechnology industry
Industry Median: -140.3 vs FRA:RTQ1: -114.45

Avacta Group Net Margin % Historical Data

The historical data trend for Avacta Group's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Avacta Group Net Margin % Chart

Avacta Group Annual Data
Trend Jul13 Jul14 Jul15 Jul16 Jul17 Jul18 Dec20 Dec21 Dec22 Dec23
Net Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -319.54 -881.05 -894.83 -379.49 -107.31

Avacta Group Semi-Annual Data
Jan14 Jul14 Jan15 Jul15 Jan16 Jul16 Jan17 Jul17 Jan18 Jul18 Jan19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -143.83 -693.78 -97.00 -118.11 -110.75

Competitive Comparison of Avacta Group's Net Margin %

For the Biotechnology subindustry, Avacta Group's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Avacta Group's Net Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Avacta Group's Net Margin % distribution charts can be found below:

* The bar in red indicates where Avacta Group's Net Margin % falls into.



Avacta Group Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Avacta Group's Net Margin for the fiscal year that ended in Dec. 2023 is calculated as

Net Margin=Net Income (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=-28.957/26.984
=-107.31 %

Avacta Group's Net Margin for the quarter that ended in Jun. 2024 is calculated as

Net Margin=Net Income (Q: Jun. 2024 )/Revenue (Q: Jun. 2024 )
=-14.741/13.31
=-110.75 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Avacta Group  (FRA:RTQ1) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


Avacta Group Net Margin % Related Terms

Thank you for viewing the detailed overview of Avacta Group's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Avacta Group Business Description

Traded in Other Exchanges
Address
Unit 20, Ash Way, Thorp Arch Estate, West Yorkshire, Wetherby, GBR, LS23 7FA
Avacta Group PLC is a United Kingdom-based biotechnology company. The company offers its products through three segments that are Diagnostics, Therapeutics, and Animal Health. The company is developing novel cancer immunotherapies combining its two proprietary platforms Affimer biotherapeutics and precision tumor-targeted chemotherapy. The company operates in the United Kingdom, France, South Korea, Rest of Europe, Asia, and North America.

Avacta Group Headlines

No Headlines